Evidence map›Paper›PMID 35653647›Full record

ArticleAnalytical chemistry2022

Microneedle Aptamer-Based Sensors for Continuous, Real-Time Therapeutic Drug Monitoring.

Yao Wu, Farshad Tehrani, Hazhir Teymourian, John Mack, Alexander Shaver, Maria Reynoso, Jonathan Kavner, Nickey Huang, Allison Furmidge, Andrés Duvvuri and 7 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 181 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Yao WuDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21202, United States.ORCID 0000-0003-1296-6569
Farshad TehraniDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.
Hazhir TeymourianDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.ORCID 0000-0003-0025-4732
John MackBiochemistry, Cellular and Molecular Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21202, United States.
Alexander ShaverDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21202, United States.ORCID 0000-0002-5478-5291
Maria ReynosoDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.
Jonathan KavnerDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.
Nickey HuangDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.
Allison FurmidgeDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.
Andrés DuvvuriDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.
Yuhang NieDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.
Lori M LaffelJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, United States.
Francis J DoyleHarvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, Massachusetts 02134, United States.
Mary-Elizabeth PattiJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, United States.
Eyal DassauHarvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, Massachusetts 02134, United States.
Joseph WangDepartment of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.
Netzahualcóyotl Arroyo-CurrásDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21202, United States.ORCID 0000-0002-2740-6276
University of California San Diego · USJohns Hopkins University · USHarvard University · USJoslin Diabetes Center · US

Funding

BIOCHEMISTRY, CELLULAR AND MOLECULAR BIOLOGY PROGRAMT32GM007445 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREEN, RACHEL · 1985 to 2021
$24.1M
NIGMS NIH HHS T32 GM007445
6 · The paper itself

Abstract

The ability to continuously monitor the concentration of specific molecules in the body is a long-sought goal of biomedical research. For this purpose, interstitial fluid (ISF) was proposed as the ideal target biofluid because its composition can rapidly equilibrate with that of systemic blood, allowing the assessment of molecular concentrations that reflect full-body physiology. In the past, continuous monitoring in ISF was enabled by microneedle sensor arrays. Yet, benchmark microneedle sensors can only detect molecules that undergo redox reactions, which limits the ability to sense metabolites, biomarkers, and therapeutics that are not redox-active. To overcome this barrier, here, we expand the scope of these devices by demonstrating the first use of microneedle-supported electrochemical, aptamer-based (E-AB) sensors. This platform achieves molecular recognition based on affinity interactions, vastly expanding the scope of molecules that can be sensed. We report the fabrication of microneedle E-AB sensor arrays and a method to regenerate them for multiple uses. In addition, we demonstrate continuous molecular measurements using these sensors in flow systems in vitro using single and multiplexed microneedle array configurations. Translation of the platform to in vivo measurements is possible as we demonstrate with a first E-AB measurement in the ISF of a rodent. The encouraging results reported in this work should serve as the basis for future translation of microneedle E-AB sensor arrays to biomedical research in preclinical animal models.

Indexed as

Drug MonitoringNeedlesAnimalsBiomarkersExtracellular FluidOligonucleotidesBiomarkersOligonucleotides

Identifiers

PMID35653647
PMCPMC9202557
OpenAlexW4281793692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.